on-pharmacological interventions for improving behaviour in children with AD/HD.

Not Applicable

Completed

• Conditions: Attention deficit hyperactivity disorder; Mental Health - Other mental health disorders

• Registration Number: ACTRN12619000455167
• Lead Sponsor: Peking University Sixth Hospital

Brief Summary

The results showed that the CT condition improved inhibitory function in day-to-day situations, the NFT condition improve alpha activity, and the combined condition had no transfer effect.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2017-09-01
• Study Start: 2019-03-20
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

1) screened by the Clinical Diagnostic Interviewing Scales (Barkley, 1998), a structured clinical interview based on the DSM-IV;

2) no history of head trauma with loss of consciousness

3) no history of neurological illness or other severe disease

4) no history of other psychiatric disorders described in the DSM-IV

5) naïve to any pharmacological treatment for AD/HD

6) an IQ higher than 80 on the Wechsler Intelligence Scale III for children.

Exclusion Criteria

No professional diagnosis of AD/HD.

Study & Design

• Study Type: Interventional
• Study Design: Not specified